Targeting Glycolytic Reprogramming in Cholangiocarcinoma: A Novel Approach for Metabolic Therapy
Liyuan Hao,1,2,* Shenghao Li,1,2,* Qing Peng,1,2 Junli Zhang,3 Jiali Deng,1,2 Xiaoyu Hu2 1School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, People’s Republic of China; 2Department of Infectious Diseases, Hospital of Chengdu Un...
Saved in:
| Main Authors: | Hao L, Li S, Peng Q, Zhang J, Deng J, Hu X |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-11-01
|
| Series: | Journal of Inflammation Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/targeting-glycolytic-reprogramming-in-cholangiocarcinoma-a-novel-appro-peer-reviewed-fulltext-article-JIR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SENP1-SIRT3 axis mediates glycolytic reprogramming to suppress inflammation during Listeria monocytogenes infection
by: Yan Xiong, et al.
Published: (2025-04-01) -
Indole-3-lactic acid suppresses colorectal cancer via metabolic reprogramming
by: Shizhen Zhou, et al.
Published: (2025-12-01) -
AARS2 ameliorates myocardial ischemia via fine-tuning PKM2-mediated metabolism
by: Zongwang Zhang, et al.
Published: (2025-05-01) -
PKM2-driven metabolic reprogramming in digestive system tumors: mechanisms, therapeutic advances, and clinical challenges
by: Xinyao Huang, et al.
Published: (2025-08-01) -
ETV4/ALYREF-mediated glycolytic metabolism through PKM2 enhances resistance to ferroptosis and promotes the development of intrahepatic cholangiocarcinoma
by: Xiaohui Wang, et al.
Published: (2025-04-01)